Impact of cap-assisted colonoscopy during transendoscopic enteral tubing: A randomized controlled trial

Table 1 Baseline characteristics of the study subjects

	RC group, n = 152	CC group, n = 151	P value
Age in yr, mean ± SD	44.4 ± 17.6	46.7 ± 17.0	0.248
Children1, n (%)	4 (2.6)	4 (2.6)	1.000
Male, n (%)	76 (50.0)	79 (52.3)	0.687
Body mass index in kg/m2, mean ± SD	21.1 ± 3.8	21.6 ± 3.3	0.243
Disease category, n (%)
Ulcerative colitis	46 (30.3)	42 (27.8)	0.639
Constipation	43 (28.3)	50 (33.1)	0.363
Irritable bowel syndrome	14 (9.2)	18 (11.9)	0.443
Crohn's disease	6 (3.9)	3 (2.0)	0.501
Healthy volunteers	3 (2.0)	3 (2.0)	1.000
Others2	40 (26.3)	35 (23.2)	0.527
Previous surgery, abdominal or pelvic, n (%)	38 (25.0)	33 (21.9)	0.518

¹Aged ≤ 15 years.

²Other disease categories include antibiotic-associated diarrhea, diabetes, Parkinson’s disease, Tourette's syndrome, autism, epilepsy, cirrhosis, etc. RC: Regular colonoscopy; CC: Cap-assisted colonoscopy.